YM BioSciences Reports Third Quarter 2009 Operational and Financial Results
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM, AIM:YMBA), a life sciences product development company that identifies and a…
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM, AIM:YMBA), a life sciences product development company that identifies and a…
Lantronix, Inc. (NASDAQ: LTRX), a leading provider of secure, remote device networking and data centre management techno…
Colonia Real Estate AG (ISIN: DE0006338007; WKN: 633800) posted a profit of 7.7 million Euros for the first quarter of 2…
Key points - fourth quarter: - Revenue growth of 1% - EBITDA(1) decline due to an unacceptable performance in BT Gl…
Delticom AG (German Securities Code WKN 514680, ISIN DE0005146807, stock market symbol DEX), Europe's leading Internet t…
. - Workforce grows by 880 since the end of last year - Operating result improves by 5% in the first quarter - RWE co…
. - Sales € 71.1 million (prior-year: € 80.3 million) - Operating earnings (EBIT) € 1.6 million (prior-year: € 3.1 mil…
Today Bekaert's Ordinary General Meeting of shareholders took place, with Baron Buysse, Chairman of the Board of Directo…
The Direct Manufacturing Research Center (DMRC) at the University of Paderborn officially started operations today. P…
Alibaba.com, the global leader in B2B e-commerce, and Logo Group ("LOGO"), one of the largest software developers and re…